CD56, CD57, HBME1, CK19, Galectin-3 and p63 immunohistochemical stains in differentiating diagnosis of thyroid benign/malign lesions and NIFTP

CD56, CD57, HBME1, CK19, Galectin-3 and p63 immunohistochemical stains in differentiating diagnosis of thyroid benign/malign lesions and NIFTP

Detection of thyroid carcinoma has been steadily increased in the past few decades. After the recognition of NIFTP, also gain importance to differentiate benign tumors (follicular adenoma) from follicular patterned variants of papillary thyroid carcinoma (invasive and infiltrative follicular variant...

Full description

Bibliographic Details
Main Authors: Ebru Tastekin, Elif Keskin, Nuray Can, Sule Canberk, Ayse Mut, Ezgi Erdogan, Nurtac Asa, Sibel Güldiken, Atakan Sezer, Meltem Azatcam
Format: Article
Language:English
Published: Termedia Publishing House 2020-03-01
Series:Polish Journal of Pathology
Subjects:
thyroid lesions
differential diagnosis
ck19
galectin-3
cd56
cd57
p63
hbme1
Online Access:https://www.termedia.pl/CD56-CD57-HBME1-CK19-Galectin-3-and-p63-immunohistochemical-stains-in-differentiating-diagnosis-of-thyroid-benign-malign-lesions-and-NIFTP,55,39928,1,1.html

Internet

https://www.termedia.pl/CD56-CD57-HBME1-CK19-Galectin-3-and-p63-immunohistochemical-stains-in-differentiating-diagnosis-of-thyroid-benign-malign-lesions-and-NIFTP,55,39928,1,1.html

Similar Items